EAM
CRBP icon

Exome Asset Management’s Corbus Pharmaceuticals CRBP Stock Holding History

Exome Asset Management’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.73M Sell
184,914
-49,222
-21% -$466K 1.07% 36
2026
Q1 		$2.2M Buy
234,136
+94,593
+68% +$796K 1.14% 38
2025
Q4 		$1.14M Sell
139,543
-90,419
-39% -$1.12M 0.54% 51
2025
Q3 		$2.91M Sell
229,962
-47,355
-17% -$450K 1.76% 20
2025
Q2 		$1.91M Sell
277,317
-12,373
-4% -$89.9K 1.42% 29
2025
Q1 		$1.54M Buy
+289,690
New +$2.56M 1.37% 34
2024
Q3 		– Sell
-84,790
Closed -$3.84M – 67
2024
Q2 		$3.84M Sell
84,790
-3,056
-3% -$129K 3.42% 6
2024
Q1 		$3.45M Buy
+87,846
New +$2.17M 2.95% 8

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Exome Asset Management's CRBP Position: Q2 2026 in Review

Exome Asset Management reduced its Corbus Pharmaceuticals (CRBP) stake by 21% in Q2 2026, selling an estimated $466K and leaving 184,914 shares worth $1.73M. The position accounts for 1.07% of the portfolio, ranked #36.

Exome Asset Management first reported a position in CRBP in Q1 2024 and has held it in 8 quarters since. The position peaked at $3.84M in Q2 2024. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • Exome Asset Management held 184,914 shares of Corbus Pharmaceuticals worth $1.73M as of Q2 2026.
  • Exome Asset Management sold 49,222 Corbus Pharmaceuticals shares in Q2 2026, an estimated $466K.
  • Corbus Pharmaceuticals made up 1.07% of Exome Asset Management's portfolio in Q2 2026, its #36 holding.
  • Exome Asset Management first reported a position in Corbus Pharmaceuticals in Q1 2024 and has held it in 8 quarters since.
  • Exome Asset Management's Corbus Pharmaceuticals position peaked at $3.84M in Q2 2024.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on Exome Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.